Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe
Τheodoros Karampitsakos, Paolo Spagnolo, Nesrin Moğulkoç, et al.
Respirology (2022) Vol. 28, Iss. 1, pp. 56-65
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Precision medicine advances in idiopathic pulmonary fibrosis
Τheodoros Karampitsakos, Brenda Juan-Guardela, Argyris Tzouvelekis, et al.
EBioMedicine (2023) Vol. 95, pp. 104766-104766
Open Access | Times Cited: 66
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision
John A. Mackintosh, Gregory J. Keir, Lauren Troy, et al.
Respirology (2024) Vol. 29, Iss. 2, pp. 105-135
Open Access | Times Cited: 21
Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis
C.Y. Perrot, Τheodoros Karampitsakos, Jose D. Herazo‐Maya
AJP Cell Physiology (2023) Vol. 325, Iss. 4, pp. C1046-C1057
Open Access | Times Cited: 35
The novel molecular mechanism of pulmonary fibrosis: insight into lipid metabolism from reanalysis of single-cell RNA-seq databases
Xiangguang Shi, Yahui Chen, Mengkun Shi, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Mast-cell expressed membrane protein-1 is expressed in classical monocytes and alveolar macrophages in idiopathic pulmonary fibrosis and regulates cell chemotaxis, adhesion, and migration in a TGFβ-dependent manner
C.Y. Perrot, Τheodoros Karampitsakos, Avraham Unterman, et al.
AJP Cell Physiology (2024) Vol. 326, Iss. 3, pp. C964-C977
Open Access | Times Cited: 8
Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis
Τheodoros Karampitsakos, Apostolos Galaris, Serafeim Chrysikos, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 16
A real-world study of antifibrotic drugs-related adverse events based on the United States food and drug administration adverse event reporting system and VigiAccess databases
M. He, Taoran Yang, Jianguo Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Smoking status and clinical outcome in idiopathic pulmonary fibrosis: a nationwide study
Hee‐Young Yoon, Hoseob Kim, Yoon‐Jong Bae, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Current state of signaling pathways associated with the pathogenesis of idiopathic pulmonary fibrosis
Yang Zhou, Tingting Ling, Weihong Shi
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
Walking the path of treatable traits in interstitial lung diseases
Francesco Amati, Paolo Spagnolo, Christopher J. Ryerson, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Sinomenine attenuates pulmonary fibrosis by downregulating TGF-β1/Smad3, PI3K/Akt and NF-κB signaling pathways
Fuqiang Yao, Minghao Xu, Lingjun Dong, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis
Zezhou Shi, Min Zhou, Jingfang Zhai, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Closed Access | Times Cited: 4
Evaluation of comorbidity burden on disease progression and mortality in patients with interstitial pneumonia with autoimmune features: A retrospective cohort study
Elena K. Joerns, Michelle A. Ghebranious, Traci N. Adams, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0316762-e0316762
Open Access
A Comprehensive Review of Interstitial Lung Abnormalities
Yuben Moodley, John A. Mackintosh
Respirology (2025)
Open Access
Advances in management of pulmonary fibrosis
Julia Lachowicz, Daniel P. Steinfort, Natasha Smallwood, et al.
Internal Medicine Journal (2025)
Closed Access
Basal and AT2 Cells Promote IPF-Lung Cancer Co-occurrence via EMT: Single-cell Analysis
Cheng Ren, Yawan Zi, Xiaobin Zhang, et al.
Experimental Cell Research (2025) Vol. 448, Iss. 2, pp. 114578-114578
Open Access
Clinical analysis of patients with idiopathic pulmonary fibrosis concurrent with surgery resectable lung cancer: a retrospective cohort study from perspective of ILD physicians
Qi Chen, Yujie Shi, Ruxuan Chen, et al.
BMC Pulmonary Medicine (2025) Vol. 25, Iss. 1
Open Access
Factors influencing long-term outcomes in fibrotic interstitial lung disease (F-ILD) diagnosed through multidisciplinary discussion (MDD): a prospective cohort study
Yu-Wan Liao, Ming-Cheng Liu, Yucheng Wu, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 3
Methodologies for the collection of parameters to estimate dust/soil ingestion for young children
Alesia Ferguson, Foluke Adelabu, Helena M. Solo‐Gabriele, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 3
Lung Cancer and Interstitial Lung Diseases
Fotios Drakopanagiotakis, Ekaterina Krauss, Ira Michailidou, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2837-2837
Open Access | Times Cited: 3
An update on current and emerging drug treatments for idiopathic pulmonary fibrosis
Athina Trachalaki, N Sultana, Athol U. Wells
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 10, pp. 1125-1142
Closed Access | Times Cited: 8
Up-regulated SPP1 increases the risk from IPF to lung cancer via activating the pro-tumor macrophages
Tingting Chen, Jiayu Guo, Liqiang Ai, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 5751-5764
Open Access | Times Cited: 7
Novel 3D-based deep learning for classification of acute exacerbation of idiopathic pulmonary fibrosis using high-resolution CT
Xinmei Huang, Wufei Si, Xu Ye, et al.
BMJ Open Respiratory Research (2024) Vol. 11, Iss. 1, pp. e002226-e002226
Open Access | Times Cited: 2
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice
Τheodoros Karampitsakos, Fotios Sampsonas, Jose D. Herazo‐Maya, et al.
Current Opinion in Pulmonary Medicine (2023) Vol. 29, Iss. 5, pp. 416-426
Closed Access | Times Cited: 6
Nicotinamide N-methyltransferase mediates lipofibroblast–myofibroblast transition and apoptosis resistance
Mohammad Rehan, Brian Deskin, Ashish Kurundkar, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 8, pp. 105027-105027
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top